{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:41:34Z","timestamp":1788489694244,"version":"build-2803163510"},"reference-count":56,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The nuclear receptor (NR) subclass, retinoid X receptors (RXRs), exert immunomodulatory functions that control inflammation and metabolism via homodimers and heterodimers, with several other NRs, including retinoic acid receptors. IRX4204 is a novel, highly specific RXR agonist in clinical trials that potently and selectively activates RXR homodimers, but not heterodimers. In this study, in vivo IRX4204 compared favorably with FK506 in abrogating acute graft-versus-host disease (GVHD), which was associated with inhibiting allogeneic donor T-cell proliferation, reducing T-helper 1 differentiation, and promoting regulatory T-cell (Treg) generation. Recipient IRX4204 treatment reduced intestinal injury and decreased IFN-\u03b3 and TNF-\u03b1 serum levels. Transcriptional analysis of donor T cells isolated from intestines of GVHD mice treated with IRX4204 revealed significant decreases in transcripts regulating proinflammatory pathways. In vitro, inducible Treg differentiation from naive CD4+ T cells was enhanced by IRX4204. In vivo, IRX4204 increased the conversion of donor Foxp3\u2212 T cells into peripheral Foxp3+ Tregs in GVHD mice. Using Foxp3 lineage-tracer mice in which both the origin and current FoxP3 expression of Tregs can be tracked, we demonstrated that IRX4204 supports Treg stability. Despite favoring Tregs and reducing Th1 differentiation, IRX4204-treated recipients maintained graft-versus-leukemia responses against both leukemia and lymphoma cells. Notably, IRX4204 reduced in vitro human T-cell proliferation and enhanced Treg generation in mixed lymphocyte reaction cultures. Collectively, these beneficial effects indicate that targeting RXRs with IRX4204 could be a novel approach to preventing acute GVHD in the clinic.<\/jats:p>","DOI":"10.1182\/blood.2020005628","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:44:21Z","timestamp":1601059461000},"page":"1090-1103","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses"],"prefix":"10.1182","volume":"137","author":[{"given":"Govindarajan","family":"Thangavelu","sequence":"first","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-6093","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Loschi","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Saha","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Osborn","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N.","family":"Furlan","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"McDonald-Hyman","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-0913","authenticated-orcid":false,"given":"Ethan G.","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Janesick","sequence":"additional","affiliation":[{"name":"Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshantha A.","family":"Chandraratna","sequence":"additional","affiliation":[{"name":"Io Therapeutics, Santa Ana, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Refaeli","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Colorado, Aurora, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Panoskaltsis-Mortari","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli P.","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Department of Immunology, Queensland Institute of Medical Research (QIMR), University of Queensland, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Hill","sequence":"additional","affiliation":[{"name":"Clinical Research Division and"},{"name":"Division of Medical Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Maillard","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4568-1092","authenticated-orcid":false,"given":"Jonathan S.","family":"Serody","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Munn","sequence":"additional","affiliation":[{"name":"Georgia Cancer Center, Augusta University, Augusta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-8414","authenticated-orcid":false,"given":"Bruce","family":"Blumberg","sequence":"additional","affiliation":[{"name":"Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysothemis","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Transplantation Immunology and Mucosal Biology, King\u2019s College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kuchroo","sequence":"additional","affiliation":[{"name":"Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Kean","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Boston Children\u2019s Hospital, Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8050-270X","authenticated-orcid":false,"given":"Keli L.","family":"Hippen","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph J.","family":"Noelle","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine, Dartmouth College, Lebanon, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-9841","authenticated-orcid":false,"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2021022516235468200_B1","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"22","key":"2021022516235468200_B2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2021022516235468200_B3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nri775","article-title":"Cytolytic pathways in haematopoietic stem-cell transplantation","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2021022516235468200_B4","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/eji.201141678","article-title":"Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4+ effector memory T cells","volume":"41","author":"Anderson","year":"2011","journal-title":"Eur J Immunol"},{"issue":"6","key":"2021022516235468200_B5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(95)90200-7","article-title":"The RXR heterodimers and orphan receptors","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"suppl 2","key":"2021022516235468200_B6","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1038\/sj.cdd.4401533","article-title":"Retinoid X receptors: X-ploring their (patho)physiological functions","volume":"11","author":"Szanto","year":"2004","journal-title":"Cell Death Differ"},{"issue":"1","key":"2021022516235468200_B7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear Receptors, RXR, and the Big Bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"issue":"12","key":"2021022516235468200_B8","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/eji.200535366","article-title":"An essential role for Rxr alpha in the development of Th2 responses","volume":"35","author":"Du","year":"2005","journal-title":"Eur J Immunol"},{"issue":"4","key":"2021022516235468200_B9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2567.2007.02595.x","article-title":"Disruption of Rxra gene in thymocytes and T lymphocytes modestly alters lymphocyte frequencies, proliferation, survival and T helper type 1\/type 2 balance","volume":"121","author":"Stephensen","year":"2007","journal-title":"Immunology"},{"issue":"1","key":"2021022516235468200_B10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00032.2013","article-title":"Leukocyte homing, fate, and function are controlled by retinoic acid","volume":"95","author":"Guo","year":"2015","journal-title":"Physiol Rev"},{"issue":"4","key":"2021022516235468200_B11","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","article-title":"Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression","volume":"181","author":"Xiao","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"2021022516235468200_B12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-immunol-041015-055427","article-title":"Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System","volume":"34","author":"Larange","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"2021022516235468200_B13","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood-2012-11-470252","article-title":"Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration","volume":"122","author":"Aoyama","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2021022516235468200_B14","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.4049\/jimmunol.1800899","article-title":"Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality","volume":"202","author":"Thangavelu","year":"2019","journal-title":"J Immunol"},{"issue":"19","key":"2021022516235468200_B15","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1182\/blood-2012-08-445130","article-title":"A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease","volume":"121","author":"Chen","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2021022516235468200_B16","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.18632\/oncotarget.7191","article-title":"Selective brain penetrable Nurr1 transactivator for treating Parkinson\u2019s disease","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"2021022516235468200_B17","first-page":"1016","article-title":"Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis","volume":"8","author":"Chandraratna","year":"2016","journal-title":"Am J Transl Res"},{"issue":"8","key":"2021022516235468200_B18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/carcin\/bgh122","article-title":"Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid","volume":"25","author":"Balasubramanian","year":"2004","journal-title":"Carcinogenesis"},{"issue":"9","key":"2021022516235468200_B19","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.4049\/jimmunol.168.9.4495","article-title":"Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway","volume":"168","author":"Stephensen","year":"2002","journal-title":"J Immunol"},{"issue":"5","key":"2021022516235468200_B20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.celrep.2018.10.002","article-title":"Differential Roles of IL-2 Signaling in Developing versus Mature Tregs","volume":"25","author":"Fan","year":"2018","journal-title":"Cell Rep"},{"issue":"14","key":"2021022516235468200_B21","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1021\/jm0100584","article-title":"Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes","volume":"44","author":"Vuligonda","year":"2001","journal-title":"J Med Chem"},{"issue":"4","key":"2021022516235468200_B22","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.153.4.1836","article-title":"FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation","volume":"153","author":"Blazar","year":"1994","journal-title":"J Immunol"},{"issue":"9","key":"2021022516235468200_B23","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1182\/blood-2007-05-087940","article-title":"Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)","volume":"110","author":"Taylor","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2021022516235468200_B24","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pbio.0060152","article-title":"The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas","volume":"6","author":"Refaeli","year":"2008","journal-title":"PLoS Biol"},{"issue":"9","key":"2021022516235468200_B25","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2006-04-017780","article-title":"Phase 1\/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"108","author":"Blazar","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2021022516235468200_B26","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"issue":"20","key":"2021022516235468200_B27","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1182\/blood-2009-06-204669","article-title":"Acute graft-versus-host disease: from the bench to the bedside","volume":"114","author":"Soci\u00e9","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2021022516235468200_B28","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1172\/JCI119873","article-title":"Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response","volume":"100","author":"Wells","year":"1997","journal-title":"J Clin Invest"},{"issue":"4","key":"2021022516235468200_B29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"issue":"11","key":"2021022516235468200_B30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J Exp Med"},{"issue":"26","key":"2021022516235468200_B31","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2021022516235468200_B32","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2021022516235468200_B33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4049\/jimmunol.1402861","article-title":"Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease","volume":"195","author":"Pierini","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"2021022516235468200_B34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncomms1272","article-title":"The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells","volume":"2","author":"Sekiya","year":"2011","journal-title":"Nat Commun"},{"issue":"7","key":"2021022516235468200_B35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1101\/gad.9.7.769","article-title":"A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1","volume":"9","author":"Perlmann","year":"1995","journal-title":"Genes Dev"},{"issue":"4","key":"2021022516235468200_B36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(95)90075-6","article-title":"Unique response pathways are established by allosteric interactions among nuclear hormone receptors","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"18","key":"2021022516235468200_B37","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1182\/blood-2011-03-340315","article-title":"Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and ROR\u03b3t in mice","volume":"118","author":"Yu","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2021022516235468200_B38","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1172\/JCI4285","article-title":"Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease","volume":"102","author":"Cooke","year":"1998","journal-title":"J Clin Invest"},{"issue":"3","key":"2021022516235468200_B39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2015.02.003","article-title":"Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program","volume":"42","author":"Brown","year":"2015","journal-title":"Immunity"},{"issue":"7","key":"2021022516235468200_B40","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1172\/JCI43706","article-title":"Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice","volume":"121","author":"Ma","year":"2011","journal-title":"J Clin Invest"},{"issue":"10","key":"2021022516235468200_B41","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.1500117","article-title":"Cytokines in Graft-versus-Host Disease","volume":"194","author":"Henden","year":"2015","journal-title":"J Immunol"},{"issue":"7136","key":"2021022516235468200_B42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/nature05652","article-title":"Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin","volume":"446","author":"Suzuki","year":"2007","journal-title":"Nature"},{"issue":"1","key":"2021022516235468200_B43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-016-1217-5","article-title":"Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis","volume":"19","author":"Xie","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2021022516235468200_B44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ni1538","article-title":"The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells","volume":"9","author":"Kano","year":"2008","journal-title":"Nat Immunol"},{"issue":"6","key":"2021022516235468200_B45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1074-7613(02)00471-5","article-title":"IFN-gamma represses IL-4 expression via IRF-1 and IRF-2","volume":"17","author":"Elser","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"2021022516235468200_B46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4049\/jimmunol.181.3.1673","article-title":"IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression","volume":"181","author":"Fragale","year":"2008","journal-title":"J Immunol"},{"key":"2021022516235468200_B47","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","article-title":"Hijacking of the AP-1 Signaling Pathway during Development of ATL","volume":"8","author":"Gazon","year":"2018","journal-title":"Front Microbiol"},{"issue":"8","key":"2021022516235468200_B48","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.bbmt.2014.04.031","article-title":"Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells\/regulatory T cells","volume":"20","author":"Park","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2021022516235468200_B49","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","article-title":"Leukocyte migration and graft-versus-host disease","volume":"105","author":"Wysocki","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2021022516235468200_B50","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0301-472X(03)00198-X","article-title":"Role of CXCR3-induced donor T-cell migration in acute GVHD","volume":"31","author":"Duffner","year":"2003","journal-title":"Exp Hematol"},{"issue":"5","key":"2021022516235468200_B51","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"issue":"2","key":"2021022516235468200_B52","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.3390\/ijms19020485","article-title":"Integrins in T Cell Physiology","volume":"19","author":"Bertoni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2021022516235468200_B53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41423-019-0312-3","article-title":"Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation","volume":"17","author":"Su","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"2021022516235468200_B54","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2021022516235468200_B55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2010-03-271940","article-title":"Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2021022516235468200_B56","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1172\/JCI39692","article-title":"PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice","volume":"119","author":"Valenzuela","year":"2009","journal-title":"J Clin Invest"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/8\/1090\/1800967\/bloodbld2020005628.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/8\/1090\/1800967\/bloodbld2020005628.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T10:33:56Z","timestamp":1696761236000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/8\/1090\/463979\/Repurposing-a-novel-anti-cancer-RXR-agonist-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,2,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020005628","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}